G'day, Richard here. As you may know, we're back and making new podcasts, but with

work commitments we may not finish a new podcast every week, so we're planning to handpick

some of our favourite episodes from our back catalogue and republish them with the updated

commentary of why we like each episode and what has changed about the subjects and the

podcasts originally had. Last time I handpicked a show, it was an episode where I spoke to

Dr Sarah Hullberg, who has shepherded one of the most important clinical studies to date

to show the effects of the key to genetic diet, treating and reversing type to diabetes.

Not also a reversing cardiovascular disease biomarkers and fatty liver disease. The next

episode I'd like to reintroduce is episode 113, Thomas Saferid may have just cured cancer.

And first off the bat, I really want to admit culpability for that totally horrid linked

baked title. That was some shocking milackey of my own right there. What I should have

said was that Professor Saferid has a novel hypothesis about tumour cells that may shake

up our treatment of cancer and has begun the experiment to test this hypothesis. I guess

that long title wouldn't have worked well as a podcast title though. The reason I chose

this subject is that this particular episode intersected in three interesting ways with my

biochem undergraduate degree. Firstly, it was recorded during my first semester and while

I was doing an undergraduate chemistry and biology subjects, I also was looking forward

to biochemistry that would come in second year. And I decided that semester to take a brief

detour into human biology and nutrition.

OMG, that was the worst subject. I literally had to wrote, learn all the things I knew to be

incorrect and parrot them off in the exam and probably forget them. For example, one of the exam

questions was explain why it's not possible for free living people to either low carb ketogenic

...